Roche reported that its human papillomavirus (HPV) self-collection solution, which was among the first available in the United States, has been approved by the US FDA. Screening for HPV can assist identify women who are at risk of getting...
Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceuticals company, proudly announced the launch of the next phase of ‘India First Heart First’ campaign.
Atraverse Medical, a medical device company spearheading cutting edge left-heart access innovation, has reported the US FDA approval of its HOTWIRE radiofrequency (RF) guidewire, a novel device that empowers zero trade left-heart access while...
Centogene NV, the crucial life science partner for data-driven answers in rare and neurological illnesses, has announced the discovery of a new small molecule alongside Evotec SE. The novel chemical has the potential to help individuals with type...
Chiesi Group, a pharmaceutical firm, declared the marking of a memorandum of understanding with Karolinska Institutet, a medical university. The understanding cements a responsibility between the two associations to team up on joint endeavors...
Mankind Pharma, a pharmaceutical firm, posted more than 65% in its final quarter profit, assisting areas of strength by request in its chronic drugs segment. The organization has also sanctioned a fundraising of up to 75 billion rupees or an...
Boehringer Ingelheim, a pharmaceutical firm, added that the domestic medication controller has endorsed a medication for Generalised Pustular Psoriasis (GPP) flares in grown-ups. The organization has secured an endorsement from the Central Drugs...
MediciNova, Inc., a biopharmaceutical firm, said that it has obtained a Notice of Allowance from the United States Patent and Trademark Office for a pending patent application for MN-166 (ibudilast) for the treatment of chlorine-induced acute...
Fortis Hospital Bannerghatta Road, recently achieved yet another significant clinical milestone with the successful completion of complex Robotic Kidney Transplant Surgeries for end-stage kidney disease
Hutchmed (China), a biopharmaceutical firm, declares that it has started a registrational stage III clinical preliminary of HMPL-306 in patients with changed isocitrate dehydrogenase (IDH) 1 or 2 backslid/refractory intense myeloid leukemia (AML)...
, CDSCO.jpg)
